Free Chat Friday (Every Friday) -- Our live chat room with stock and option alerts! Fridays, starting at 9:30 am, go to: https://goo.gl/O3l5KC use the password: freechatfriday

AveXis, Inc.
(NASDAQ : AVXS)

( )
AVXS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.32%72.110.9%$619.68m
CELGCelgene Corporation
0.06%127.651.1%$445.33m
AMGNAmgen Inc.
-0.31%167.291.1%$418.48m
BIIBBiogen Inc.
-0.93%281.771.2%$356.38m
REGNRegeneron Pharmaceuticals, Inc.
0.85%467.982.7%$321.83m
VRTXVertex Pharmaceuticals Incorporated
-0.28%148.131.9%$264.60m
ALXNAlexion Pharmaceuticals, Inc.
-0.91%133.401.9%$217.97m
ILMNIllumina, Inc.
-0.98%189.323.5%$216.35m
SRPTSarepta Therapeutics, Inc.
-0.46%36.7019.8%$138.44m
INCYIncyte Corporation
-0.45%121.192.6%$130.95m
CLVSClovis Oncology, Inc.
2.99%71.9618.0%$129.20m
KITEKite Pharma, Inc.
3.29%130.1816.1%$121.84m
TSROTESARO, Inc.
4.41%113.8614.7%$121.68m
AAgilent Technologies, Inc.
0.62%61.241.5%$119.01m
BMRNBioMarin Pharmaceutical Inc.
-0.07%80.924.4%$108.58m

Company Profile

AveXis, Inc. operates as a clinical-stage gene therapy company that engages in the research and development of technology specifically for neurological genetic disease treatment. Its proprietary gene therapy candidate, AVXS-101 has been granted orphan drug designation for the treatment of all types of spinal muscular atrophy and fast track designation for the treatment of spinal muscular atrophy type 1. The company was founded by John D. Harkey, Jr. in 2010 and is headquartered in Chicago, IL.